4//SEC Filing
Hayes Christopher G. 4
Accession 0001415889-24-025026
CIK 0001660334other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:15 PM ET
Size
5.6 KB
Accession
0001415889-24-025026
Insider Transaction Report
Form 4
Hayes Christopher G.
CHIEF LEGAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2024-10-09+50,000→ 50,000 totalExercise: $1.28Exp: 2034-10-09→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]50% of the total shares subject to the option shall vest on each of April 9, 2025 and October 9, 2025, subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001805359
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 4:15 PM ET
- Size
- 5.6 KB